Lannett Company, Inc., a generic pharmaceutical manufacturer, and Spectrum Pharmaceuticals, Inc., have announced an agreement for the manufacturing, supply, distribution and marketing of Ciprofloxacin tablets. Arthur Bedrosian, Lannett’s President, said, “We are excited about the opportunity to work with Spectrum on this venture. With a talented scientific staff, Spectrum has an excellent future in the Read more about Lannett Company, Inc. And Spectrum Pharmaceuticals, Inc. Announce Ciprofloxacin Joint Venture[…]